HER2-low breast cancerbreast cancerneoadjuvant chemotherapy
… with distinct prognostic factors for each subgroup.Conclusions HER2-low breast cancer exhibits unique clinicopathological features and differential c…
4articles mentioning diseases
8disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: HER2-low breast cancer ×
HER2-low breast cancer
This disease is selected. Its supporting articles are shown below.
Articles mentioning HER2-low breast cancer
4 articles · page 1 of 1HER2-low breast cancerHER2-low tumorshuman breast cancermetastatic breast cancerTrastuzumab deruxtecantrastuzumab-deruxtecantrastuzumabU of North TexasTrastuzumab-based treatments
… using SE-NK/Tz cells as a novel immunotherapeutic approach for HER2-low breast cancer. Our preliminary findings confirmed the targeted nature of this…
HER2-low breast cancerHER2-lowBreast CancerHER2-0 tumorsNIH NCItrastuzumab deruxtecanThe Harvard Ludwig CenterDana-Farber Cancer InstituteSusan G. Komen Foundation
…), have transformed the therapeutic landscape for patients with HER2-low breast cancer. However, the biological basis distinguishing HER2-low (IHC 1+ …
gastric and gastroesophageal junction (GEJ) adenocarcinomaHER2-amplified colorectal cancerHER2-low breast cancerHER2-positive breast cancerLeica BiosystemsIndica Labsimmune checkpoint blockadeHER2-targeted therapy
…se important biomarkers and the neighboring microenvironment.In gastric and gastroesophageal junction (GEJ) adenocarcinoma, HER2+/PD-L1+ tumors exhibited distinct immune profiles, with s…